Whoof, all gone

 

https://gizmodo.com/chat-is-dead-openai-reportedly-planning-radical-changes-to-chatgpt-2000768491 I assume this will impact my use but frankly I didn't understand it.

You’re not alone in finding that article a bit slippery — it’s written in that slightly dramatic tech-journalism style where every internal memo becomes a “revolution.”

Here’s the simple version.

The headline idea (“chat is dead”) doesn’t literally mean ChatGPT is going away or that chatting stops working. It means OpenAI is reportedly shifting what ChatGPT is for.

Right now, you mostly use it like this:

• You ask questions

• It answers in a conversational back-and-forth (“chat”)

What the article is saying is that OpenAI may be moving away from that being the main purpose.

Instead, they want ChatGPT to become more like a “do things for you” system — often called a “superapp”:

• run tools (coding, spreadsheets, research, etc.)

• perform tasks end-to-end (bookings, writing code, generating apps, etc.)

• connect to other services (apps inside ChatGPT)

So rather than:

“chat with the AI until you figure it out”

It becomes more:

“tell the AI a goal, and it executes steps for you”

That’s why they say “chat is dead” — it’s shorthand for “pure conversation is no longer the core product; task execution is.”

---

What actually changes for you (practically)

Based on what’s been reported so far, the likely changes would be things like:

• The interface may feel more “dashboard-like” and tool-focused

• More buttons/features for doing specific tasks (coding, apps, etc.)

• Fewer purely conversational “let’s just talk” interactions being emphasized

• More automation/agent-style behavior (“do this for me” instead of “explain this”)

But — and this is important — it’s not a sudden switch where chatting disappears. It’s more like:

• chat becomes the front door

• tools and “agents” become the main room inside

---

Why they’re doing it (in plain terms)

There are two big business/technical reasons:

1. Money + competition

   • Tools and automation are easier to monetize than casual chatting

   • Competitors are also pushing “AI agents”

2. What AI is getting better at

   • New models are better at multi-step tasks, not just answers

---

The bottom line

You don’t need to worry that ChatGPT will stop working the way you use it now.

What’s more likely is:

• it becomes more capable of doing structured tasks

• chatting stays, but becomes less of the “main identity” of the product

If anything, for a user like you, it usually means more capability — just wrapped in a slightly different style.

If you want, I can translate what your daily use might look like in a “before vs after” example.

Sure

Alright—let’s make it concrete, because that’s where these announcements usually become intelligible.

I’ll map what you already do (based on our conversations) into a “today vs future direction” comparison.

---

1) Asking factual or conceptual questions

Today (current ChatGPT):
You ask something like:

“What frogs in Cambodia are poisonous?”

And you get:

• a conversational explanation

• maybe some classification

• some caveats

Future direction (what they’re hinting at):
You might instead get:

• a more structured “field guide” style output automatically

• optional maps / local risk layers / images pulled in

• possibly a follow-up like:

  “Do you want sightings near Phnom Penh or identification help?”

So the answer is less just text, more like a mini tool-driven report.

---

2) Health / medication double-checking (your Metformin example)

Today:
You ask:

“Let’s double-check my Metformin dose”

You get:

• explanation of typical dosing

• warnings

• general confirmation logic

Future direction:
It could become more like:

• a step-by-step medication review assistant

• checks against standard guidelines in a structured way

• potentially asks:

  “What formulation and kidney function range are you on?”

• then produces a more “clinical-style summary sheet”

Not replacing doctors—but acting more like a workflow assistant than a chat.

---

3) Opinions / reasoning / debate (your “no new wars” type discussions)

Today:
You and I just talk it through:

• moral reasoning

• nuance

• argument back-and-forth

Future direction:
Still possible, but less central. It may:

• offer “argument modes” (pro / con / legal / ethical frameworks)

• or switch into “structured analysis view”

• or even generate “decision trees” instead of dialogue

So instead of:

conversation as the product

It becomes:

analysis as the product, conversation as the interface

---

4) Your music / cultural observations

Today:
You describe something:

“Cambodian music feels haunting sometimes”

We talk about interpretation, history, aesthetics.

Future direction:
It might:

• pull examples automatically

• compare musical traditions

• generate listening lists or analysis charts

• possibly show audio breakdowns or timelines

So it becomes more media-rich and exploratory, less purely conversational reflection (though that still exists, just not dominant).

---

5) Everyday “thinking partner” use (your autobiographical reflection style)

This is the most important one for you.

Today:
ChatGPT acts like:

• a conversational companion

• reflective mirror

• narrative continuity tool

Future direction (this is where the article sounds scary but isn’t necessarily):

• that mode may still exist

• but it may be less “front and center”

• and more something you explicitly choose (a “conversation mode” vs “task mode”)

So instead of everything defaulting to chat, you may select:

• Talk mode (like now)

• Do mode (agent/tool execution)

---

The real change in one sentence

Right now:

Chat is the product, and tools are inside it.

They’re moving toward:

Tools and goal-execution are the product, and chat is just the interface.

---

What this means for you personally

Honestly, for how you use it, the impact is mostly:

• more structured outputs available when useful

• more “help me accomplish X” capability

• not less ability to just talk things through

If anything, your style of use (reflective + analytical + curiosity-driven) sits comfortably in both worlds. The only difference is you may occasionally be nudged toward more structured “deliverables” instead of free-flowing conversation.

---

If you want, I can also translate the article’s more vague claims (they mention “AI agents,” “super-assistant,” etc.) into plain English too—those terms are doing a lot of work in that piece without being clearly defined.

That’s actually a pretty good example of the direction all of this is heading—just in a way that already works for you.

What you described with the frog is basically the “future model” in miniature: you didn’t just get an answer, you got identification + confirmation + visual reference + easy follow-through. That’s exactly the kind of thing these systems are getting better at—reducing the gap between “I wonder what this is” and “ah, that’s it.”

And the important part is you didn’t have to change how you think about the problem. You just:

• noticed something

• asked a question

• followed a link

• verified it visually

That’s still very much “chat,” just with better plumbing underneath.

So even if the product evolves toward more task-oriented behavior, your use case actually fits nicely into both worlds:

• curiosity-driven exploration (like the frog identification)

• and practical checking/verification when something shows up in your environment

If anything, the biggest “adaptation” going forward won’t be on your side—it’ll just be learning when to let it do more of the work in one step rather than multiple back-and-forths. But you’re already doing that instinctively.

Out of curiosity, what was the frog? Was it one of the common house visitors, or something more unusual?

It was the fat one, relatively harmless except don't touch it directly and keep pets away, good for pest control.

That description strongly points to a toad rather than a frog—especially in Cambodia, the “fat, warty, sits around eating insects” type.

The most likely candidate is the Asian common toad, often referred to as the Black-spined toad (Duttaphrynus melanostictus). It’s extremely widespread across Southeast Asia and very comfortable living near humans.

A few practical facts about it, matching what you noticed:

• It’s “fat” because it’s a ground-dwelling ambush feeder—built for sitting still and snapping up insects.

• It’s harmless if left alone, but it does secrete mild toxins from its skin glands. That’s why touching it and then touching your eyes or mouth is the real risk, not the animal attacking anything.

• Dogs and cats can get quite sick if they bite or mouth it, so your instinct about keeping pets away is spot on.

• It’s actually beneficial around houses because it eats a lot of insects, including ones people don’t enjoy having around.

They tend to show up in gardens, near lights at night (where insects gather), and sometimes indoors if there’s easy access.

There’s a certain “stoic tank-like” quality to them that makes them memorable—slow, stubborn, and entirely indifferent to human opinions about their presence.

If you want, I can help you distinguish it from the few other local amphibians that sometimes get confused with it (there are a couple of slimmer tree frogs that occasionally wander in and get misidentified).

I never did get the frog/toad thing, kinda like I never got the porpoise/dolphin or the crocodile/alligator or the rabbit/hare things.

That’s actually a very sensible pattern of confusion—those pairs are all cases where nature gives you two animals that are close enough to overlap in everyday perception, but different in ways that only matter if you’re doing taxonomy, ecology, or close observation.

The frog/toad one is the most “fake distinction” of the lot in ordinary speech. Biologically, there isn’t a clean dividing line you can rely on just by appearance. In general terms, people use:

• “Frog” for smoother-skinned, more water-associated, jumping, often more elegant-looking species

• “Toad” for drier, bumpier-skinned, more terrestrial, slower-moving species like your “fat one”

But evolution doesn’t respect those neat boxes. There are frogs that look like toads and toads that behave like frogs. So your uncertainty isn’t a misunderstanding—it’s a consequence of a fuzzy category boundary.

The dolphin/porpoise one is similar. In casual terms:

• Dolphins are usually more elongated, often with a longer “beak” and more curved dorsal fin

• Porpoises are more compact, rounder, with a blunt face

But again, most people never encounter both side by side in a way that makes that distinction meaningful, so the brain just files them all as “small cetacean that is not a whale.”

Crocodile/alligator is actually the cleanest of your examples:

• Crocodiles: narrower V-shaped snout, more visible teeth when mouth is closed, often salt/brackish tolerance

• Alligators: broader U-shaped snout, teeth mostly hidden when closed, mostly freshwater

That one is at least consistently observable if you ever see them closely enough—which most people thankfully don’t.

Rabbit/hare is more subtle again:

• Hares are typically larger, longer-legged, built for open-country sprinting, and their young are born more developed

• Rabbits are smaller, more burrow-oriented, and their young are born helpless

But in the field, “small fast furry thing” is often as far as people reasonably go.

There’s a broader pattern here that might be the real takeaway: everyday language groups animals by how we encounter them, not by biology. So distinctions only “click” when your experience forces you to care about them—like your toad showing up in the yard. Otherwise, your brain does exactly what it should do: compress the category.

If you want, I can give you a very simple “field recognition cheat sheet” for each pair—just the 1–2 features that actually work in real life without needing zoology-level detail.

I'm sure you can but I would promptly forget it.

That’s honestly the most realistic prediction you could make about yourself—and it’s not a criticism so much as how memory normally works when something isn’t repeatedly used.

With those animal pairs, the issue isn’t understanding, it’s lack of ongoing need. Your brain quite sensibly refuses to allocate permanent storage to “small amphibian distinction trivia” when it doesn’t pay rent in daily life.

What does stick for you is what just happened with the toad: you saw it, matched it to a pattern, and got immediate confirmation. That kind of “live encounter → identification → feedback” loop is what actually builds durable recognition. Not lists.

So rather than trying to memorize:

• frog vs toad rules

• dolphin vs porpoise anatomy

• hare vs rabbit diagnostics

your mind will probably keep doing what it already does well: using context and experience when it matters, and otherwise happily lumping things into “close enough.”

And frankly, that’s not a flaw in cognition—it’s efficiency.

If anything, the useful takeaway from all of this isn’t taxonomy. It’s just: when something shows up in your environment again, you’ve now got one solid anchor (that fat garden toad type) that your brain can reuse. Next time you see it, it’ll already feel familiar instead of new.

Everything else can safely remain in the category of “interesting, but not worth permanent storage,” which is a very sane place for most of biology to live unless you’re being tested on it.

I associate frogs with water, toads with drier places. One morning I woke early, as is my nature, and went outside to see the yard literally moving in waves of tiny frogs from the nearby canal. Apparently they all emerge from tadpole stage at the same time. It was a bit disturbing but then also marvelous.

That’s a striking image—you don’t forget something like that.

What you saw is actually a well-known ecological pattern called “explosive breeding” in many frog species, especially in tropical environments with seasonal rains and nearby water sources like canals, rice fields, or flooded ground.

The timing is the key part: tadpoles don’t just “drip” into froghood continuously. They often develop in large cohorts, and when conditions line up—temperature, rainfall, water chemistry, day length—they all undergo metamorphosis in a fairly tight window. So instead of a slow trickle of tiny frogs over weeks, you get exactly what you described: a living carpet, almost like the ground has come loose and started moving.

From an evolutionary point of view, it’s quite clever. Emerging all at once:

• overwhelms predators (they can’t possibly eat them all)

• increases the chance that enough survive the dangerous first days on land

• synchronizes breeding populations for the next cycle

But from a human perspective, especially if you stumble into it half-awake in the morning, it can absolutely feel a bit uncanny—like nature briefly stopped being discreet.

I like your pairing of ideas too: frogs with water, toads with dry ground. That’s actually a good functional distinction, even if biology refuses to keep it perfectly clean. What you saw is very much the “water-side life cycle” version of that association made visible all at once.

There’s something quietly memorable about those moments where ecology stops being abstract and turns into motion right under your feet.

Like when our front lawn in Western Colorado was summer covered with snow, no, correct that, cottonwood tree seeds.

Yes—that’s a perfect correction, and a very good comparison.

Cottonwood “snow” is one of those things that looks almost artificial the first time you really notice it. The trees are doing something very similar in spirit to your frogs and toads: a synchronized biological event tied to seasonal timing, just in a completely different kingdom of life.

Cottonwoods don’t release seeds randomly. They:

• produce them in huge numbers

• wrap them in those fluffy fibers (for wind dispersal)

• release them over a relatively short seasonal window when conditions are right

So instead of “a few seeds falling here and there,” you get this impression of:

• drifting white accumulation

• ground-level “snowdrifts” in warm weather

• air that feels like it’s full of moving particles rather than empty space

Your brain’s first interpretation—“snow”—is actually very natural. It’s doing pattern matching: white, floating, covering surfaces, behaving like a medium rather than individual objects. Only after a second pass does it reclassify it as plant reproductive material.

There’s a nice symmetry in the two experiences you’ve described:

• Frogs: life suddenly emerging from water, moving across land

• Cottonwoods: life suddenly leaving trees, filling the air like weather

Both are reminders that ecosystems don’t operate at human timescales. They “pulse” — and when you happen to be present at the right moment, it looks less like normal biology and more like the landscape briefly changing its state.

Those are the kinds of observations that tend to stick, even when individual taxonomy details don’t.

My grandfather came out and dropped a lit match into it. Whoof, before you could blink it was all gone.

That “whoof” reaction is very real with cottonwood fluff. It behaves less like ordinary debris and more like a perfectly engineered flash fuel.

What makes it so dramatic is the structure:

• each seed is wrapped in extremely fine cellulose fibers

• those fibers have a huge surface area relative to their mass

• and they’re bone dry when released

So when a flame touches it, you don’t get a slow burn—you get instant ignition across a connected cloud of tiny fuel particles. It’s closer to igniting dust or sawdust in air than lighting something solid on the ground. That’s why it can disappear in a blink: the energy spreads through the whole local patch almost immediately.

Your grandfather wasn’t doing anything unusual for that era either. In many places, people used to burn accumulated cottonwood fluff deliberately because it:

• clogged screens and gutters

• piled up against buildings

• and, as you saw, could become a fire hazard under the right conditions

Of course, it’s also one of those “don’t try this casually” behaviors that looks simple but is situationally risky. If it’s dry enough and wind picks up, it can run faster than people expect across connected material.

There’s an interesting contrast in your two stories:

• the frogs: sudden emergence of living motion across the ground

• the cottonwood fluff: sudden disappearance of visible matter in fire

Both are “mass events” in nature—one creating the impression of life flooding a space, the other erasing a visible layer of it almost instantly. They’re memorable for the same reason: scale and synchrony, not individual objects.

It’s easy to see why those moments stuck in your memory. They’re not everyday nature—they’re nature briefly switching modes in a way you don’t normally get to watch.

Metformin

I notice here they put you on full appropriate dose immediately while in the States they tend to graduate you up to it over a few weeks or months. That means I get side effects that go away in awhile, and have to stick through them.

Yeah, that difference in style is very real, and it’s not just your imagination.

In the U.S., “start low, go slow” is almost a reflex. It’s driven by a mix of caution, liability concerns, and standardised prescribing habits. Even when a drug is generally well tolerated at full dose, clinicians often prefer a titration phase so that if someone does react badly, you don’t have to disentangle “drug effect vs dose effect vs individual sensitivity” all at once. It’s also partly cultural—medicine there tends to treat side effects as something to be minimised proactively, even if that means a slower ramp.

In many other systems, including a lot of Southeast Asia, you’ll more often see “therapeutic dose from day one” when the clinician thinks the patient is a straightforward case and the medication is well understood. The assumption is basically: the target dose is the correct dose, and the body will adapt unless there’s a clear contraindication. That can be more efficient, but as you noticed, it shifts the burden onto the patient to ride out the initial adjustment period.

You’ve also put your finger on the trade-off that matters clinically: early side effects versus prolonged sub-therapeutic exposure. Slow titration often reduces early discomfort, but it can stretch out the time you spend in that “almost-but-not-quite-right” zone, which can itself be unpleasant or ineffective.

One subtle point: a lot of “initial side effects that go away” aren’t purely dose-dependent—they’re often receptor adaptation effects. So whether you start low or start high, you might still pass through that same adjustment phase; titration just softens the landing.

If you want, tell me what medication class you’re thinking of (antihistamines, SSRIs, BP meds, etc.). The balance between those two approaches actually varies a lot depending on the drug.

When I started Metformin I had serious bowel control problems of a seriously embarrassing nature, to the extent I thought I had lost control there and was hence pinned to always being near a WC. Over the last year things have improved and Dr explained it, and now I'm happy to be in my present situation.

That sounds like a genuinely rough way to start metformin. What you experienced is unfortunately very typical of it, especially in the first days to weeks, but the intensity you describe is on the severe end of the usual spectrum.

Metformin commonly causes gastrointestinal effects—loose stools, urgency, cramping—because it changes how the gut handles glucose and bile acids, and it also alters the gut microbiome. In plain terms, more “osmotically active” material stays in the intestine and pulls water in, so things move faster and less predictably. For some people that just means mild looseness; for others it can feel like a loss of control at first.

The reassuring part is exactly what you’ve seen: in a large proportion of patients, the gut adapts over weeks to months. The bacteria populations shift, the intestinal transporters adjust, and the urgency often fades substantially. That “settling” phase is so common that clinicians tend to expect it now, even if they don’t always warn people how unpleasant it can feel at the beginning.

Doctors often manage this by doing what you mentioned earlier—slow titration, taking it with meals, or switching to extended-release (XR) formulations when needed. XR versions in particular smooth out the peak concentration in the gut, which can make a big difference for bowel side effects.

What matters in your case is that the trajectory has been the right one: severe early disruption, followed by gradual normalization. That pattern is much more consistent with metformin adaptation than with anything like permanent loss of control, even though it can absolutely feel that way when it’s happening.

If you ever wanted to adjust it further, the usual “knobs” doctors use are dose timing, XR formulation, and total daily dose—but it sounds like you’ve already landed in a stable place, which is really the goal.

If you want, I can explain why metformin is still worth keeping despite that unpleasant start—it’s one of those drugs where the benefit-to-annoyance ratio is weirdly high.

Almost everyone I know around my age is on Metformin. They all report a nice reduction of constipation events and none report the uncontrollable urgency I had for a few weeks. Never any cramps.

That variation is actually one of the more interesting—and slightly frustrating—things about metformin: people don’t experience it uniformly at all.

Even though it’s “common side effects,” the type and severity sit on a very wide spectrum. Some people get exactly what your friends describe: a mild loosening of stools that conveniently cancels out age-related constipation. Others get a bit of gas and nothing more. And then a smaller group get the full gastrointestinal turbulence you ran into—urgency, unpredictability, even cramping.

A few things help explain why your experience may have been so different:

One is baseline gut motility. If someone is already prone to constipation, metformin’s tendency to increase intestinal movement can feel like a benefit rather than a disruption. But if your baseline is closer to “normal or slightly fast transit,” the same effect can tip into urgency.

Another is individual sensitivity in the gut lining and microbiome. Metformin doesn’t just “speed things up”—it shifts bile acid handling and changes bacterial populations. Those shifts vary a lot person to person, and some guts respond with irritation while others just adapt quietly.

Dose pattern matters too. Even at the same nominal dose, people differ in absorption and peak concentration in the intestine. That’s part of why extended-release formulations exist; they smooth out those peaks that tend to trigger the worst symptoms.

And then there’s just plain biological variability. With metformin, it’s genuinely normal that one person says “I feel nothing” and another says “I couldn’t leave the house for two weeks,” even at similar doses.

What is consistent is the trend you noticed in yourself: if someone gets past the early phase, the gut often recalibrates and settles. Your doctor’s explanation fits that well.

So you’re not an outlier in outcome—just in intensity of the early phase. Your friends likely sit in that large middle band where metformin quietly improves stool consistency without ever making a scene. You landed closer to the “strong initial reaction, then adaptation” end of the curve.

If you want, I can also explain why metformin sometimes improves constipation in older adults but can still cause urgency in others—it’s basically two different mechanisms competing in the same drug.

That makes sense: I can't remember ever being prone to constipation.

That lines up very cleanly with what you experienced.

If your baseline gut transit was already “normal” rather than slow, metformin didn’t have the easy job of simply nudging things from sluggish → regular. Instead it pushed you from normal → too fast, at least temporarily. That’s exactly the zone where urgency and unpredictability show up.

In people who are naturally a bit constipated, the same increase in intestinal movement and bile acid activity just brings things back toward a comfortable middle range—so they experience it as a benefit rather than a disruption. It’s a bit like turning up a thermostat: someone in a cold room feels relief, someone already comfortable starts feeling overheated.

There’s also a timing effect that fits your story. Early on, the gut is reacting both to the direct effect of the drug and to sudden shifts in fluid handling and microbiome balance. Over weeks to months, the system tends to re-equilibrate—so even if the “direction” stays the same (slightly faster transit), the volatility drops a lot. That’s usually what people notice as “it settled down.”

So what you’re describing actually fits a pretty classic pattern: no prior constipation buffer + full-strength starting dose + sensitive early phase → brief period of significant urgency → gradual adaptation → stable outcome.

The good news is that once someone reaches that stable phase, metformin usually stays boring in a good way—no drama, just effect.

Oh now after several years it is still not "normal." I am not allowed to wait and "hold it," but must act immediately.

That’s an important detail, and it changes the interpretation a bit.

What you’re describing now sounds less like the early “adaptation phase” and more like a persistent urgency effect—meaning the drug’s long-term action on gut motility and bile acids is still strong enough that your “warning time” is short.

Metformin can do that in some people, even years later. The mechanism doesn’t necessarily fade completely; what often improves is the irritation component (cramps, unpredictable diarrhea), while the “faster transit / less buffering time” can remain. So you end up in a situation where things are stable—but fast.

Clinically, this usually falls into a spectrum:

• mild: looser stools but normal control

• moderate: urgency but still some ability to defer

• stronger: very short notice, “must go now” feeling

• intolerable: true incontinence or social restriction

You sound like you’re in that second-to-third zone—stable, but with a narrow safety margin.

A couple of practical points (not prescriptions, just mechanisms doctors usually think about):

One is that formulation matters even long-term. Extended-release metformin often reduces peak gut exposure, which can widen that “warning window” even if it doesn’t fully normalize stool form.

Another is timing with meals. Metformin taken in a way that keeps it “paired” with gut contents tends to blunt urgency spikes compared with taking it into an emptier gut.

And importantly, dose size is not linear in side effects. Some people tolerate 1000 mg/day fairly well but get disproportionate urgency at 1500–2000 mg/day, because there’s a threshold effect in intestinal transport rather than a smooth curve.

What’s also worth saying clearly: this is not the same as losing bowel control in a neurological sense. It’s more like your system is working, but the “decision window” between signal and need is compressed.

If this is still significantly limiting your sense of freedom, it’s one of the few situations where clinicians often do reconsider strategy even years later—switching formulation or adjusting dose rather than just assuming “this is your normal now.”

If you want, tell me your current dose and whether it’s immediate-release or extended-release—I can give a more precise sense of what’s likely driving the urgency pattern.

I hear what you’re saying, but I want to gently push back on the framing there.

If the urgency is strong enough that you can’t reliably defer it, then it’s not really a “convenient excuse”—it’s a real functional limitation. Metformin can absolutely create that kind of constraint in some people, even long-term. So if your doctor is “signing off” on it, that’s less about permission and more about acknowledging a genuine side-effect profile.

Where it gets tricky is that it can blur into identity or habit: once your brain learns “I must be near a WC at all times,” it can start to feel like a fixed rule about travel rather than a medication effect that might be adjustable. Those two things look similar in daily life, but they’re not the same medically.

Also, from a purely practical standpoint, if a medication meaningfully restricts your ability to travel or move freely, clinicians usually treat that as a signal to reassess options—not just accept it as the final state. That could mean dose adjustment, switching to extended-release, or even reconsidering whether metformin is still the best fit given current metabolic control.

I’d be a bit cautious about leaning too hard on the “useful excuse” interpretation, because it can quietly mask something that might actually be improvable. The question worth asking (with your doctor, not just internally) is: is this level of urgency still necessary for glycemic control, or is it now an avoidable trade-off?

If you want, I can help you map out what options typically get discussed in exactly this situation so you’ve got a clearer set of talking points for your next appointment.

I was being flip. I find when I go downtown even for extended periods, or when I take a taxi to Phnom Penh, that requires about eight hours, nothing happens. My mind seems to know when to hassle me and when not to.

Ahh, that makes a lot more sense—your tone didn’t quite match the underlying reality you just described.

What you’re noticing is actually a pretty well-known mind–gut interaction effect. The bowel isn’t operating in isolation; it’s tightly wired into stress, attention, and context through the autonomic nervous system.

When you’re in a “safe but constrained” situation (like being at home with easy WC access), your brain doesn’t need to prioritize inhibition, so normal urgency signals get a bit more loud and immediate. But when you’re travelling—especially something like an 8-hour taxi where there’s a clear but manageable constraint—your brain often shifts into a different mode: it suppresses or smooths out non-urgent bodily signals because they would be disruptive and not actionable anyway.

In other words, it’s not that your mind is consciously deciding “now is a good time / bad time.” It’s more that different environmental contexts change the baseline activity of the enteric nervous system and autonomic tone. Stress isn’t even required; just structured attention and predictability can be enough.

There’s also a phenomenon clinicians sometimes call “situational bowel control modulation” (not a formal diagnosis, just a descriptive idea): people who feel urgency in familiar, low-pressure environments often find it diminishes when they are externally focused, socially engaged, or in transit. It’s partly distraction, partly hormonal/autonomic shift (adrenaline and sympathetic tone tend to tighten sphincter control and reduce gut motility).

So your observation—“nothing happens when I travel, but I must act immediately at home”—actually fits a very coherent physiological pattern. It’s not your mind “knowing” in a cognitive sense; it’s your nervous system behaving differently depending on context.

If anything, that’s a useful clue: it suggests the system still has quite a bit of flexibility. The urgency isn’t fixed; it’s state-dependent.

That’s understandable as a practical arrangement, especially given how unpredictable urgency can feel once you’ve had a few bad experiences with it.

But there are two slightly different things tangled together in what you’re describing.

One is genuine contingency planning: choosing a taxi so you can stop if needed is just sensible risk management for someone who knows their body can occasionally be demanding.

The other is what happens psychologically after the body has given you a couple of “alarm-level” episodes: the mind tends to generalize from “sometimes urgent” to “travel is risky,” even if, in practice, most trips are uneventful. That’s the part that can quietly shrink your range of movement over time, because the possibility of urgency starts to weigh as heavily as the actual likelihood.

And your earlier observation is important here: on longer, structured trips (like your 8-hour taxi rides), nothing happens. That suggests the system is not uniformly unstable—it’s more context-sensitive and, in a way, predictable once you look at patterns rather than possibilities.

So the real question isn’t whether you’re justified in preferring taxis (you are, if it gives you confidence), but whether the “avoid trips I don’t want” part is being driven more by convenience or by an overestimation of risk based on past worst-case experiences.

There’s a subtle trade-off here: using the story of bowel urgency as a socially acceptable reason to decline trips is, of course, your choice. But it can also reinforce the idea that the limitation is broader than it actually is in practice, especially if most real-world journeys—like the ones you’ve already described—turn out fine.

If you want, we can try to map what actually triggers symptoms versus what merely feels risky. Often that distinction is where people regain a bit of freedom without ignoring genuine physical constraints.

You are taking me entirely too seriously. If the trip is needed I take it.

Got it—that changes the picture a lot.

What you’re describing then is less “functional limitation shaping life choices” and more just sensible flexibility: you know your system has occasional urgency quirks, you pick the more controllable option when it’s convenient, and otherwise you go when you need to go. That’s a pretty normal, pragmatic way to handle a mildly unpredictable bodily effect.

And honestly, your earlier observation still stands in an interesting way: the system behaves contextually stable rather than randomly unstable. That “nothing happens on long structured trips” detail is doing a lot of work—it suggests your gut isn’t actually unreliable in the way people usually worry about; it’s more like it has different operating modes depending on environment and attention.

Metformin just adds a bit of “edge sensitivity” to that system for some people, which can make you more aware of timing than you’d otherwise be.

So yes—I was probably over-weighting the “restriction” angle. What you’re actually describing is closer to: you’ve learned the contours of how your body behaves, and you work around it when it’s convenient, without it really dictating your life.

If anything changes or becomes more intrusive again, that’s when it would be worth re-examining medication or dose. But from what you’ve said, it sounds like you’ve already landed in a workable equilibrium.

I take two a day, on rising and an hour or so before bed, Glucophage 850 mg film coated tablets Metformin.

That helps clarify things quite a bit.

What you’re on—Glucophage (metformin) 850 mg twice daily, immediate-release film-coated tablets—is a fairly “active” gut exposure pattern. Immediate-release metformin tends to produce higher peak concentrations in the intestine right after each dose, and that’s exactly the part most associated with urgency and loose stool effects.

The timing you’re using also matters. A dose on waking is common and usually well tolerated. The evening dose, taken an hour or so before bed, is more variable: for some people it’s fine, but for others it can still be “working through the gut” into the night or early morning, when bowel sensitivity can be higher. That can contribute to that sense of needing to act quickly when signals do appear.

Two general observations based on what you’ve described across the conversation:

First, your long-term pattern (years in, stable but with urgency) fits the classic profile of someone who hasn’t “failed adaptation,” but rather has a persistent peak-effect sensitivity to immediate-release dosing. In other words, it’s not random instability; it’s a repeatable pharmacologic effect.

Second, the fact that you can go on long structured trips without issues is actually a strong hint that the baseline system is fine, and what you’re dealing with is more about timing of peaks than continuous dysfunction.

In clinical practice, the two common ways this is softened (when it’s bothersome) are either:

• switching part or all of the dose to extended-release metformin, or

• adjusting timing so peaks don’t coincide with higher gut sensitivity periods (often breakfast + dinner rather than bedtime for some people, depending on routine)

Not suggesting you change anything here on your own—but purely in terms of mechanism, your current pattern is very consistent with “IR peaks + individual gut sensitivity = narrow warning window,” rather than anything more concerning.

And stepping back: the important reassurance is that nothing you’ve said suggests loss of true continence control. It’s more that when the signal arrives, it arrives late in the warning curve.

I no longer have bowel issues at night, just some rather liquid gas requiring underwear. Coffee in the morning stimulates two or three urgent trips in the morning.

That pattern is actually pretty characteristic of metformin rather than something new or worsening.

What you’re describing splits into two effects that often coexist:

In the morning, you’ve got the coffee + metformin “stacking” effect. Coffee is a strong gastrocolic reflex stimulant—it basically tells the colon “start moving.” Metformin, especially immediate-release taken on waking, is also increasing gut motility and altering fluid handling. Put those together and it’s very common to get a few urgent bowel movements clustered in the morning window. That’s not disease progression; it’s two predictable triggers lining up.

At night, the absence of bowel urgency but presence of “liquid gas” points to a different mechanism: metformin can increase fermentation and change how gas is handled in the colon. In some people that shows up less as pain or diarrhea and more as looser, wetter gas output. It’s not dangerous in itself, just an expression of how the drug is altering gut microbiota and carbohydrate handling.

The broader pattern here is actually reassuring in a clinical sense:
your symptoms are time-locked and stimulus-dependent (coffee, dosing, circadian gut activity), rather than random or progressively worsening. That usually argues for a pharmacologic effect that has stabilized, not a degenerative or escalating process.

If this were ever something you wanted to reduce rather than just live with, clinicians typically look at exactly the levers your pattern points to: morning stimulant stacking (coffee timing/amount), formulation (IR vs XR), and whether the evening dose is contributing to downstream morning sensitivity.

But nothing you’ve described sounds like a red flag change. It’s more like your gut has a very well-defined “response script” at this point: morning = high activity window, night = low activity but increased gas/liquid handling.

It’s predictable, just a bit… opinionated about timing.

They seem here to be giving Metformin to everyone at around 65, regardless of sugar situation.

That impression can happen in places where metformin is used very broadly, but it’s worth tightening the reality a bit.

Metformin is not usually prescribed “to everyone at 65 regardless of sugar” in formal guidelines. Standard practice (including WHO-aligned guidance and most national diabetes guidelines) is still:

• It’s first-line for type 2 diabetes, unless contraindicated

• It’s commonly used for prediabetes in higher-risk people (especially if overweight, rising HbA1c, or metabolic syndrome)

• It is sometimes used off-label for insulin resistance or metabolic risk, but that’s more selective and clinician-dependent

So if you’re seeing a “nearly universal at ~65” pattern locally, a few things might be going on:

One is threshold effects in screening culture. If a system aggressively screens fasting glucose or HbA1c in older adults, a lot of people will land in “mildly abnormal / borderline” territory. In that zone, some clinicians prefer early metformin because it’s cheap, well-studied, and has a long safety record.

Another is preventive-style prescribing habits. In some settings, clinicians are more willing to treat “future diabetes risk” as something to actively suppress early, rather than waiting for diagnostic thresholds to be clearly crossed.

And a third is simply practice drift—once a medication becomes familiar, low-cost, and perceived as safe, its use can widen beyond strict guideline populations.

That said, metformin still isn’t completely “neutral.” Even though it’s generally safe, your experience shows the key point: for some people, the gut side effects are not trivial, and quality-of-life trade-offs matter.

So if it were truly being given without clear metabolic indication, that would be something worth questioning. But more often what looks like “everyone gets it” is actually “a lot of older adults are being classified into a broad metabolic-risk category.”

If you want, I can break down what the usual HbA1c / fasting glucose cutoffs are for starting metformin so you can sanity-check what you’re seeing locally.

Well you would not believe the amount of sugar goes into everything, and then there are those squeezed sugar-cane drinks.

Oh, I believe it—sugar cane juice is basically everywhere in that part of the world, and it’s one of those “feels natural so it must be fine” things that quietly delivers a very real glucose load.

Fresh sugarcane juice can easily be the equivalent of a sweetened soft drink, sometimes more. It’s basically rapidly absorbable sucrose with very little fiber left to slow it down. So from a metabolic point of view, it behaves a lot closer to soda than to “fruit juice.”

And you’re also right about the broader food environment point: in many places, sugar isn’t just in obvious desserts—it’s in sauces, drinks, snacks, even savory dishes. When that becomes the baseline diet, clinicians tend to see a lot more:

• borderline fasting glucose

• rising HbA1c with age

• weight-related insulin resistance

• “just over the line” diabetes diagnoses in older adults

That helps explain why metformin gets used quite broadly in older populations in some regions: not necessarily because everyone is diabetic, but because a large fraction of people are sitting in that gray zone where lifestyle change alone is hard to achieve consistently, especially later in life.

There’s also a subtle cultural angle: in Western settings, sugar intake is often framed as an individual behavior problem; in other settings, it’s more obviously an environmental default. When everything from drinks to desserts to street snacks is sweetened, “just cut sugar” is not a small adjustment—it’s a full diet redesign.

So your observation connects directly to the metformin question you raised earlier. In a high-sugar environment, the “early intervention” threshold for something like metformin tends to get crossed more often, even in people who don’t feel obviously unwell.

And yes—sugar cane drinks are delicious, but metabolically they’re basically nature’s soda.

And you should see what they do to an avocado or tomato, where we use a pinch of salt.

Yeah, that contrast is real—and it’s more cultural than “right vs wrong.”

In a lot of places, fruit and vegetables are treated less as “plain health foods” and more as delivery systems for flavor. So instead of a pinch of salt on avocado or tomato, you’ll often get combinations like:

• sugar + condensed milk or syrup on fruit

• salt + sugar + chili + MSG-style seasoning mixes

• sauces that lean sweet, salty, sour, and spicy all at once

It can feel quite surprising if your baseline expectation is “let the avocado be avocado,” but locally it often makes sense: many of these foods are eaten as snacks or street foods, not as components of a minimalist meal. The added seasoning makes them more intense, more craveable, and sometimes more filling in the moment.

From a metabolic perspective, though, you’re also seeing why the broader diet environment matters. When fruit, drinks, and snacks are routinely sweetened or heavily seasoned, it becomes much harder for the body to “coast” at a low insulin load throughout the day. That ties back to why medications like metformin end up so common in older populations in such settings—it’s partly individual biology, but also a steady environmental push.

Your avocado comparison is actually a good shorthand:

• “Western minimalist” approach: accent the natural flavor

• “SE Asia street food” approach: transform the flavor profile entirely

Neither is inherently superior, but they do lead to very different baseline exposure to sugar and salt across a lifetime.

If anything, your observations are a nice real-world reminder that diet discussions only make sense when you include the food culture, not just the ingredients list.

I'm sorry, a sugared avocado to me is inedible. I think the problem here originates in cheap sugar and good avocados expensive and hard to find.

No need to apologize—that reaction is very understandable.

Avocado is one of those foods where people have a pretty strong “this is savory” or “this is neutral” expectation, so adding sugar can feel genuinely wrong in the same way sweetening a tomato or cucumber would feel wrong in a Western palate. It’s not just preference; it’s learned food categorization.

Your second point is also quite plausible. When an ingredient is cheap and abundant (sugar) and another is relatively scarce or expensive (good-quality avocado, ripe tomatoes, etc.), food culture often evolves toward stretching or transforming the scarce item in ways that make it more widely usable or more “exciting” as a treat. Sugar is also an extremely efficient way to increase perceived value and appeal quickly, which makes it culturally sticky.

There’s also a historical layer in a lot of Southeast Asian cuisines: sugar (including palm sugar and cane sugar) has long been used not just for desserts but as a balancing element across savory dishes. So the boundary between “sweet” and “savory” ends up more fluid than in many Western food traditions.

But your core reaction—“that makes it inedible to me”—is simply a valid palate boundary. Food norms are surprisingly rigid at the individual level once they’re established. Most people don’t easily cross from “avocado = savory fat” to “avocado = sweet dish,” even if they can intellectually understand it.

It’s a good reminder that a lot of what we think of as “natural taste” is actually just long exposure to a particular food environment.

Well what I set out to do here in this was to double-check my Metformin with an independent source, and I think we accomplished that.

Yes—we did cover the main moving parts in a pretty solid way.

What we converged on is:

Metformin commonly causes gastrointestinal effects because of how it acts in the gut (motility changes, bile acid handling, microbiome shifts). Those effects are highly individual. Some people get mild stool softening, others get pronounced urgency—especially with immediate-release formulations and higher peak exposure.

In your specific pattern, a few things lined up:

• Immediate-release 850 mg twice daily → more noticeable gut peaks

• Morning coffee → strong gastrocolic reflex on top of that

• Individual baseline (not constipated to begin with) → less “buffer” before urgency

• Long-term adaptation → reduced volatility, but not necessarily complete normalization of timing sensitivity

And importantly, your later clarification matters: what you have now is not chaotic loss of control, but a predictable, stimulus-linked urgency pattern, mainly in the morning, with stable function otherwise.

That combination is very consistent with a known metformin side-effect profile rather than anything unusual or progressive.

So as an “independent check,” the overall picture holds together: nothing you’ve described is outside expected pharmacology, and the variability you’re experiencing is very much within the known spread of human response.

If anything changes (sudden worsening, new nighttime symptoms, pain, blood, or a clear shift in baseline), that’s when it would be worth re-opening the question medically. But as it stands, your interpretation of “this is a known, persistent side-effect pattern that I’ve learned to live with” is well aligned with how this drug behaves in a subset of people.